What are the benefits of Zhiling Capsules

Zhiling Capsule is a commonly used medicine in daily clinical medicine. Because its main ingredients are Chinese medicinal materials such as Astragalus, Codonopsis, Ligustrum lucidum, Atractylodes macrocephala and Poria, it is safe and reliable and has multiple functions, so it is deeply trusted by patients and friends. Zhiling Capsules can treat diseases such as loss of appetite, insomnia, fatigue, etc. It also has the effects of nourishing yin and moistening dryness, and invigorating qi and strengthening the spleen. However, any drug has its contraindications and adverse reactions. Patients with mental illness, diabetes and other diseases should not use this drug. Therefore, before choosing drug treatment, patients need to base their decision on their physical condition and follow the doctor's advice.

1. Zhiling Capsules

Zhiling Capsules replenish qi and strengthen the spleen, nourish yin and moisten dryness. Used to relieve symptoms such as fever, pain, cough, asthma, difficulty swallowing, loss of appetite, insomnia, fatigue, weight loss, etc. in advanced cancers of the lungs, esophagus, stomach, liver, colon, rectum, breast, etc.

2. Ingredients

Astragalus, Ligustrum lucidum, Polygonatum sibiricum (processed), Adenophora australis, Ophiopogon japonicus, Codonopsis pilosula, Atractylodes macrocephala, Poria cocos, Gynostemma pentaphyllum, Scutellaria baicalensis, Agrimonia sinensis, Polygala tenuifolia (core removed), Tangerine peel (processed), Dioscorea opposita, Euryale ferox, Licorice, Indomethacin, Dexamethasone acetate, Spironolactone, Famotidine, Diazepam.

3. Properties

This product is a capsule, the contents are brown powder, with a small amount of white spots visible, and a slightly bitter odor.

IV. Functions and indications

Invigorate Qi and strengthen the spleen, nourish Yin and moisten dryness. Used to relieve symptoms such as fever, pain, cough, asthma, difficulty swallowing, loss of appetite, insomnia, fatigue, weight loss, etc. in advanced cancers of the lungs, esophagus, stomach, liver, colon, rectum, breast, etc.

V. Specifications

Each pill weighs 0.43g (containing the chemical drugs indomethacin 11.11mg, dexamethasone acetate 0.24mg, spironolactone 5.55mg, famotidine 6.5mg, and diazepam 0.55mg).

VI. Usage and Dosage

Oral administration, 3 capsules at a time, 3 times a day, after meals. For the elderly, the fatigued, and the weak, the dose can be changed to 2 pills each time according to the actual situation. For pain relief, some patients still find it difficult to fully control the pain by taking 3 pills each time, so the dose can be changed to 4 pills each time or 3 pills 4 times a day.

VII. Adverse Reactions

Occasionally there may be nausea, vomiting, constipation, and mouth ulcers. Some patients developed mild abnormalities in liver function and tachycardia after taking the medicine.

8. Taboo

1. It is contraindicated for patients with diabetes, hypertension, active gastric and duodenal ulcers, gastric bleeding, gastric cancer without surgical resection, ulcerative colitis, epilepsy, Parkinson's disease, mental illness or a history of severe mental illness;

2. Patients who are allergic to this product or aspirin, or to other non-steroidal anti-inflammatory and analgesic drugs are contraindicated.

3. Contraindicated if allergic to adrenal cortical hormone drugs;

4. It is forbidden to use after recent gastrointestinal anastomosis surgery;

5. It is contraindicated for patients with uncontrolled viral, bacterial, or fungal infections;

6. It is forbidden for patients with liver and kidney dysfunction.

IX. Precautions

1. The clinical study observation course of this product is 14 days. Long-term use should be cautious, and it is generally not advisable to stop the drug suddenly. If you need to stop the drug, you should gradually reduce the dosage within one week and then stop using it.

2. The fever this product is used to treat is cancer fever, and other antipyretic drugs should not be used at the same time. Fever patients will sweat after taking it, and some patients may sweat profusely. If you sweat too much, you should replenish enough water and electrolytes. Fever caused by infection is not within the scope of indications for this product and should be used in conjunction with antibiotics.

3. A small number of patients experience mild facial flushing and edema after taking the medicine. Thickening of subcutaneous fat on the abdominal wall does not affect continued medication and gradually disappears after stopping the medication.

4. While taking this product, you should check your liver and kidney function and blood count regularly.

5. For patients with cured gastric or duodenal ulcers, if they need to take the medicine, they should take gastric mucosa protection and anti-ulcer drugs together.

6. During the use of this product, blood sugar and urine sugar should be checked regularly. If fasting blood sugar is between 6.5 and 7.0 mmol/L for two consecutive times, the dosage should be reduced and hypoglycemic drugs should be given. If blood sugar levels do not drop after taking hypoglycemic drugs, stop taking this product.

7. After taking this product, some patients may experience drowsiness, sleepiness, soreness and fatigue in the lower limbs. This is related to the sedative and hypnotic effects of this drug. A very small number of patients may experience calf muscle cramps (cramps) and other symptoms of low calcium, which generally do not require treatment. Severe cases require calcium supplementation.

8. If gastrointestinal bleeding occurs while using this product, anti-ulcer drugs such as antacids should be given intravenously. If stomach discomfort or hunger-related stomach pain occurs, anti-ulcer drugs can be taken.

9. Currently, there is no clinical research data on the use of this drug in pregnant women, lactating women, and children.

10. Athletes should use with caution.

10. Pharmacological Action

Pharmacodynamic tests show that this product has a significant inhibitory effect on the growth of mouse cervical cancer U14, Lewis lung cancer and liver cancer HAC; it can inhibit the swelling of the mouse paws caused by carrageenan and the swelling of the mouse ears caused by croton oil; it can reduce the number of twisting times caused by intraperitoneal injection of acetic acid in mice; it has a significant antipyretic effect on fever in rats caused by carrageenan; and it has an improving effect on the decrease in mouse white blood cell, thymus, spleen index and serum hemolysin caused by cyclophosphamide. The acute toxicity test of this product showed that the LD50 and 95% confidence limit of oral administration to mice were 41.986g/kg (1.78-2.210g/kg); the long-term toxicity test of rats showed that oral administration of 1.0g/kg of this product for 16 weeks had a certain damaging effect on liver cells.